Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Abstract
Excess free iron generates oxidative stress that hallmarks diseases of aging. The observation that patients with Alzheimer's disease or Parkinson's disease show a dramatic increase in their brain iron content has opened the possibility that disturbances in brain iron homeostasis may contribute to the pathogenesis of these disorders. While the reason for iron accumulation is unknown, iron localization correlates with the production of reactive oxygen species in those areas of the brain that are prone to neurodegeneration. A role for iron is also proposed in atherosclerosis, a further frequent disorder of aging. We will review experimental evidences for an involvement of iron in these diseases and discuss some mouse models with impairment in iron-related genes that may be useful to study the role of iron in these disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Iron chelation improves endothelial function”
From Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples (2010) · cites this paper as Altamura and Muckenthaler 2009
In the citing paper
“Excessive amounts of total iron will decrease furin activity because transcription of furin is modulated by cellular concentrations of iron, leading to decreased furin protein concentrations which thereby favours β secretase activity and enhances the amyloidogenic pathway.”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [78]
In the citing paper
“By contrast, iron deficiency will increase furin activity, thereby enhancing α secretase and stimulating the non-amyloidogenic pathway.78,80”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [78]
In the citing paper
“APP translation might therefore be up-regulated in conditions of iron excess, increasing the amount of APP available to enter the amyloidgenic pathway, which is favoured by decreased furin activity.78”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [78]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630 · cited 1×
“Atherosclerosis can be initiated by the injury of endothelial cells of the arterial wall that leads to enhanced permeability [121].”
BackgroundMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786 · cited 1×
“In 96% of cases, it is caused by a GAA nucleotide repeat expansion inside the first intron of the frataxin gene resulting in reduced frataxin mRNA expression [183].”
Background
Cited by
Items 201–300 of 378
Xu, W., Liu, W., & Yu, W. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.12.001 · Cited by 26
Magnetic domains oscillation in the brain with neurodegenerative disease
Kletetschka, G., Bazala, R., Takáč, M., & Svecova, E. (2021) · Scientific Reports · doi:10.1038/s41598-020-80212-5 · Cited by 25
The interplay between mitochondrial protein and iron homeostasis and its possible role in ageing
Mallikarjun, V., Sriram, A., Scialò, F., & Sanz, A. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2013.12.015 · Cited by 25
“…of cellular and mitochondrial iron with age in various different organisms and tissues in parallel to an increase in oxidative damage (Massie et al., 1983) and indeed, iron accumulation has been implicated in many neurodegenerative diseases(Altamura and Muckenthaler, 2009; Aquino et al., 2009).”
Mati, S. S., Singharoy, D., Samai, B., Konar, S., Santra, N., Pal, S., Das, P., & Murmu, S. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.02.020 · Cited by 25
The Association Between Anemia of Chronic Inflammation and Alzheimer’s Disease and Related Dementias
Andreev, A., Erdinc, B., Shivaraj, K., Schmutz, J.-L., Levochkina, O., Bhowmik, D., Farag, F., Money, K. M., Primavera, L. H., Gotlieb, V. K., et al. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200178 · Cited by 26
“Excess iron could promote the conversion of hydrogen peroxide (H2O2) to hydroxyl radical (–OH) with high toxic properties and trigger A production, and thus, A plaques [34, 37, 38, 47].”
BackgroundExcessive Iron and α-Synuclein Oligomer in Brain are Relevant to Pure Apathy in Parkinson Disease
Wang, F., Yu, S., Zuo, L.-J., Cao, C.-J., Hu, Y., Chen, Z.-J., Piao, Y., Wang, Y., Wang, X., Chen, S., et al. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716632918 · Cited by 27
Borophene Quantum Dots with Strong Photoluminescence for Selective Metal Ion Sensing
Aswal, S., Ghosh, K., & Giri, P. K. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.4c01204 · Cited by 24
CAMKK2-CAMK4 signaling regulates transferrin trafficking, turnover, and iron homeostasis
Sabbir, M. G. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00575-0 · Cited by 28
“In the aging brain, iron content gradually increases [24], but in neurodegenerative diseases, specifically Alzheimer’s disease (AD), brain iron content showed a dramatic increase [25].”
BackgroundChange in the characteristics of ferritin induces iron imbalance in prion disease affected brains
Singh, A., Qing, L., Kong, Q., & Singh, N. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.012 · Cited by 23
Maulik, U., Sen, S., Mallik, S., & Bandyopadhyay, S. (2018) · BMC Genetics · doi:10.1186/s12863-017-0574-7 · Cited by 23
“Iron toxicity effected the aging of brain [33] Known”
BackgroundBrain Iron Dysregulation and the Risk of Ageing White Matter Lesions
Gebril, O. H., Simpson, J. E., Kirby, J., Brayne, C., & Ince, P. G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8161-y · Cited by 23
“Neurodegenerative diseases, such as AD, PD, HD and ALS, are associated with changes in the level of iron in the brain (Brar et al. 2009; Altamura and Muckenthaler 2009; Boll et al. 2008; Salazar et al. 2006).”
BackgroundER Stress and Iron Homeostasis: A New Frontier for the UPR
Oliveira, S. J., de Sousa, M. A. B., & Pinto, J. P. (2010) · Biochemistry Research International · doi:10.1155/2011/896474 · Cited by 26
“Regardless of the yet uncertain mechanisms driving such deposition, the significance of inherent oxidative stress to neuronal damage has been increasingly recognized [101].”
Flunarizine related movement disorders: a nationwide population-based study
Jhang, K.-M., Huang, J., Nfor, O. N., Tung, Y., Ku, W.-Y., Jan, C., & Liaw, Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-37901-z · Cited by 22
Mou, X., Pilozzi, A. R., Tailor, B. A., Yi, J., Cahill, C. M., Rogers, J. T., & Huang, X. (2020) · Biomedicines · doi:10.3390/biomedicines8030045 · Cited by 25
Serum hepcidin / ferroportin levels in bipolar disorder and schizophrenia
Altun, İ. K., Atagün, M. İ., Erdogan, A. R., Yenilmez, D., Yusifova, A., Şenat, A., & Erel, Ö. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126843 · Cited by 22
Chung, S.-J., Lim, H.-S., Lee, M. Y., Lee, Y., Yoon, K. J., & Park, C. (2022) · Nutrients · doi:10.3390/nu14194023 · Cited by 22
Ascorbic Acid Modulation of Iron Homeostasis and Lysosomal Function in Trabecular Meshwork Cells
Xu, P. A., Lin, Y., Porter, K. M., & Liton, P. B. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0183 · Cited by 21
“Elevated levels of catalytic metal ions have been demonstrated during aging and in chronic inflammatory diseases.(29,30) While there is no direct evidence of changes in iron content with age or in disease in the outflow pathway, prior data from our laboratory have shown changes in expression of the iron homeostasis ge…”
Micronutrient Deficiencies in Older Adults in Latin America: A Narrative Review
la Cruz-Góngora, V. V. D., Palazuelos‐González, R., & Domínguez-Flores, O. (2023) · Food and Nutrition Bulletin · doi:10.1177/03795721231214587 · Cited by 22
“95,96 To date, this correlation has not been shown to be causal.”
Shu, R., Zhang, L., Zhang, H., Li, Y., Wang, C., Su, L., Zhao, H., & Wang, G. (2020) · Journal of Pain · doi:10.1016/j.jpain.2020.03.007 · Cited by 20
Pathogenic mechanism and modeling of neuroferritinopathy
Cozzi, A., Santambrogio, P., Ripamonti, M., Rovida, E., & Levi, S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03747-w · Cited by 22
Deloncle, R., & Guillard, O. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140765 · Cited by 20
“[15, 16, 20] may contribute to the formation of free radicals such as ◦OH via the Fenton reaction [21, 22] and account for oxidative stress-induced neurological damage [23, 24].”
Yildirim, A. E., Koçer, M. B., Demir, A. D., Arslan, E., & Yılmaz, M. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.04.134 · Cited by 20
Serum Cholesterol and Nigrostriatal R2* Values in Parkinson's Disease
Du, G., Lewis, M. M., Shaffer, M. L., Chen, H., Yang, Q. X., Mailman, R. B., & Huang, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035397 · Cited by 20
“Excessive accumulation of iron in neurons causes toxicity presumed to result from alterations in the ratio of ferric to ferrous iron and subsequent production of toxic hydroxyl radicals [20,21].”
BackgroundElouarzaki, K., Popescu, L. R., Gorgy, K., Holzinger, M., Amarandei, C.-A., Ungureanu, E., & Cosnier, S. (2015) · Electrochemistry Communications · doi:10.1016/j.elecom.2015.08.024 · Cited by 19
Guerreiro, C. C., Silva, B. D. R., Crespo, Â. C., Marques, L., Costa, S., Timóteo, Â., Marcelino, E., Maruta, C., Vilares, A., Matos, M., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.07.017 · Cited by 19
Han, S., Auger, C., Castonguay, Z., Appanna, V. P., Thomas, S. C., & Appanna, V. D. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6413-9 · Cited by 20
“Aconitase [62] Complex I [4, 6] Glyceraldehyde 3-phosphate dehydrogenase [64]”
BackgroundCheng, C., Wang, D., Cao, X., Luo, Q., Lu, Y., & Zhu, L. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25147 · Cited by 20
“JOURNAL OF CELLULAR BIOCHEMISTRY1926 IRP1 AND IRON METABOLISM UNDER HYPOXIA acids, and lipids [Rouault and Klausner, 1996; Altamura and Muckenthaler, 2009], mammalian cells have evolved complex mechanisms to control the concentrations of cellular iron.”
BackgroundBoualia, I., Derabli, C., Boulcina, R., Bensouıcı, C., Yıldırım, M., Yıldırım, A. B., Mokrani, E. H., & Debache, A. (2019) · Archiv der Pharmazie · doi:10.1002/ardp.201900027 · Cited by 19
Hossain, M. B., Miazie, M. R., Nur, A.-A. U., Paul, S. K., Bakar, M. A., Paray, B. A., & Arai, T. (2022) · Toxics · doi:10.3390/toxics10090536 · Cited by 19
Sarkar, P., Nandi, N., Barnwal, N., & Sahu, K. (2023) · Materials Today Chemistry · doi:10.1016/j.mtchem.2022.101341 · Cited by 20
Furtado-Filho, O. V., Borba, J. B., Dallegrave, A., Pizzolato, T. M., Henriques, J. A. P., Moreira, J. C. F., & Saffi, J. (2013) · International Journal of Radiation Biology · doi:10.3109/09553002.2013.817697 · Cited by 19
“Neurodegenerative diseases (Halliwell 2006, Altamura and Muckenthaler 2009, Uttara et al. 2009), cardiovascular (Madamanchi et al. 2005), damages resulting from the Keywords: Electromagnetic radiation (EMR), oxidative damage, antioxidant, aging, polyunsaturated fatty acid (PUFA) process of aging…”
BackgroundMetabolic inhibitors accentuate the anti-tumoral effect of HDAC5 inhibition
Hendrick, E., Peixoto, P., Blomme, A., Polese, C., Matheus, N., Cimino, J., Frère, A., Mouithys-Mickalad, A., Serteyn, D., Bettendorff, L., et al. (2017) · Oncogene · doi:10.1038/onc.2017.103 · Cited by 18
Metabolome informs about the chemical exposome and links to brain health
Orešič, M., Karu, N., Zhao, H. N., Moseley, M. A., Hankemeier, T., Wishart, D. S., Dorrestein, P. C., Fiehn, O., Hyötyläinen, T., & Kaddurah‐Daouk, R. (2025) · Environment International · doi:10.1016/j.envint.2025.109741 · Cited by 18
“These can affect mitochondrial function and neurotransmitter metabolism, leading to cognitive disturbances (Yu et al., 2024; Brewer, 2009; Altamura and Muckenthaler, 2009).”
Fish Models for Exploring Mitochondrial Dysfunction Affecting Neurodegenerative Disorders
Otsuka, T., & Matsui, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087079 · Cited by 21
Progress Towards a Consensus on Biomarkers for Alzheimer‘S Disease: A Review of Peripheral Analytes
Rembach, A., Ryan, T. M., Roberts, B. R., Doecke, J. D., Wilson, W. J., Watt, A. D., Barnham, K. J., & Masters, C. L. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.59 · Cited by 20
Kumar, M., Dhir, A., & Bhalla, V. (2010) · Dalton Transactions · doi:10.1039/c0dt00702a · Cited by 18
Lavezzi, A. M., Mohorović, L., Alfonsi, G., Corna, M. F., & Matturri, L. (2011) · BMC Pediatrics · doi:10.1186/1471-2431-11-62 · Cited by 18
“neurodegenerative diseases, notably Alzheimer’s disease, Parkinson’s disease and Huntington’s disease [43-45].”
BackgroundMapping of mitochondrial ferritin in the brainstem of Macaca fascicularis
Yang, M., Yang, H., Guan, H., Bellier, J., Zhao, S., & Tooyama, I. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.04.035 · Cited by 18
McCarthy, R. C., & Kosman, D. J. (2014) · Cell Communication and Signaling · doi:10.1186/preaccept-1742036239138335 · Cited by 18
Ahmed, S., Zengin, G., Selvı, S., Ak, G., Cziáky, Z., Jekő, J., Rodrigues, M. J., Custódio, L. M. B., Venanzoni, R., Flores, G. A., et al. (2024) · Pathogens · doi:10.3390/pathogens13090795 · Cited by 17
“Moreover, studies have shown a connection between the advancement of Alzheimer’s disease (AD) and the imbalance of iron regulation and oxidative stress [61].”
BackgroundRaj, S. K., Choudhary, B., Yadav, A., Patidar, R., Mishra, A., & Kulshrestha, V. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09259 · Cited by 17
Lu, D., Chen, E. Y. T., Lee, P., Wang, Y.-C., Ching, W., Markey, C., Gulstrom, C., Chen, L.-C., Nguyen, T. H., & Chin, W. (2014) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2013.0725 · Cited by 18
“Intracellular ROS level and signaling closely modulate early neural development and can promote O-2A progenitor cells differentiating into oligodendrocytes.(37,44,49,50) We surmised that the iron-instigated accelerated neuronal differentiation could follow a similar pathway.”
Tan, S. C., Chin, S. F., & Pang, S. C. (2017) · Journal of Sensors · doi:10.1155/2017/7576345 · Cited by 17
Ye, H., Shang, Y., Wang, H.-Y., Ma, Y., He, X., Li, W., Li, Y., & Zhang, Y. (2021) · Talanta · doi:10.1016/j.talanta.2021.122294 · Cited by 16
Facile synthesis of nitrogen-doped carbon dots and its application as sensing probes for serum iron
Wang, L., Hou, J., Li, H., Zhao, Q., Zhang, F., Zhao, J., Ding, H. Y., & Ding, L. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-3252-6 · Cited by 16
“Iron deficiency and overload can both lead to various diseases, such as anemia, Parkinson’s syndrome, Alzheimer’s disease, and cancer (Altamura and Muckenthaler 2009; Wang et al. 2012b; Ward et al. 2014).”
BackgroundKarimi-Sales, R., Ashiri, M., Hafizi, M., Kalanaky, S., Maghsoudi, A. H., Fakharzadeh, S., Maghsoudi, N., & Nazaran, M. H. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-2773-6 · Cited by 15
“(27,28) we designed the mentioned nano dendrimer as a metal chelator with a dominant affinity for iron.”
BackgroundLiao, X., Wang, W., Yang, Z.-H., Wang, J., Lin, H., Wang, Q., Wu, Y., & Liu, Y. (2013) · International Journal of Genomics · doi:10.1155/2013/606919 · Cited by 16
“Previous studies have indicated that disturbances in brain iron homeostasis may contribute to the pathogenesis of PD [40, 41].”
BackgroundIron influences on the Gut-Brain axis and development of type 2 diabetes
Fernández‐Real, J. M., Moreno‐Navarrete, J. M., & Manco, M. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1376616 · Cited by 16
Gülcan, H. O., & Orhan, İ. E. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200131103524 · Cited by 17
Asiri, A. M., Al-Amari, M. M., & Khan, S. A. (2020) · Journal of Fluorescence · doi:10.1007/s10895-020-02534-x · Cited by 15
he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments
Litvinenko, I., Emelin, А. Y., Lobzin, V. Y., Kolmakova, K. A., Naumov, K. M., Lupanov, I. A., Киливаева, Г. А., & Alizade, M. (2019) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2019-3-4-10 · Cited by 14
Hyman, L. M., & Franz, K. J. (2011) · Inorganica Chimica Acta · doi:10.1016/j.ica.2011.11.056 · Cited by 14
Ding, W., Zhang, G., Zhang, H., Xu, J., Wen, Y., & Zhang, J. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.06.082 · Cited by 15
Nuclear receptor binding factor 2 (NRBF2) is required for learning and memory
Ouyang, X., Ahmad, I., Johnson, M. S., Redmann, M., Craver, J., Wani, W. Y., Benavides, G. A., Chacko, B. K., Li, P., Young, M. E., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0433-4 · Cited by 15
Jellinger, K. A. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch21 · Cited by 15
Dynamic Changes in Brain Iron Metabolism in Neonatal Rats after Hypoxia-Ischemia
Hu, D.-W., Zhang, G., Lin, L., Yu, X.-J., Wang, F., & Lin, Q. (2022) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2022.106352 · Cited by 15
The synthesis and properties of mitochondrial targeted iron chelators
Cilibrizzi, A., Pourzand, C., Abbate, V., Reelfs, O., Versari, L., Floresta, G., & Hider, R. C. (2022) · BioMetals · doi:10.1007/s10534-022-00383-8 · Cited by 15
“Indeed, oxidative stress is a well-documented feature of AD and there is evidence to support the concept that iron contributes to oxidative stress in AD (Altamura and Muckenthaler 2009).”
BackgroundSerúlópasmín og járn. Tengsl við Alzheimersjúkdóm og Parkinsonsjúkdóm
Jóhannesson, Þ., Kristinsson, J., Þórsdóttir, G., Snædal, J., & Snædal, J. (2012) · Læknablaðið · doi:10.17992/lbl.2012.10.457 · Cited by 14
Fan, Q., Bao, G.-M., Li, S., Liu, S.-Y., Cai, X.-R., Xia, Y.-F., Li, W. H., Wang, X., Deng, K., & Yuan, H.-Q. (2022) · Analytical Methods · doi:10.1039/d2ay00629d · Cited by 13
Cigarette smoke alters the proteomic profile of lung fibroblasts
D’Anna, C., Cigna, D., Costanzo, G., Bruno, A., Ferraro, M., Vincenzo, S. D., Bianchi, L., Bini, L., Gjomarkaj, M., & Pace, E. (2015) · Molecular BioSystems · doi:10.1039/c5mb00188a · Cited by 13
Rethinking IRPs/IRE system in neurodegenerative disorders: Looking beyond iron metabolism
Yao, Z., Fu, L., Jia, F., Bi, M., Jiao, Q., Chen, X., Du, X., & Jiang, H. F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101511 · Cited by 12
Wang, S., Cong, T., Liang, Q., Li, Z., & Xu, S. (2015) · Optik · doi:10.1016/j.ijleo.2015.10.200 · Cited by 12
Yun, E. S., Akhtar, M. S., Mohandoss, S., & Lee, Y. R. (2022) · Organic & Biomolecular Chemistry · doi:10.1039/d2ob00257d · Cited by 12
Zhang, C., Liu, Z., Zhang, L., Zhu, A., Liao, F., Wan, J., Zhou, J. E., & Tian, Y. (2020) · Angewandte Chemie · doi:10.1002/ange.202006318 · Cited by 12
Lee, J. S., Kim, Y. J., Kim, S. S., Park, S., Choi, W., Bae, H. W., & Kim, C. Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-21225-0 · Cited by 13
Regulation of iron-related molecules in the rat hippocampus: sex- and age-associated differences.
Thulluri, S., Wu, M., Blough, E. R., Manne, N. D. P. K., Litchfield, A. B., & Wang, B. (2012) · PubMed · Cited by 14
Galesloot, T. E., Verweij, N., Traglia, M., Barbieri, C., van Dijk, F., Geurts-Moespot, A. J., Girelli, D., Kiemeney, L. A. L. M., Sweep, F. C. G. J., Swertz, M. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166628 · Cited by 12
“diabetes mellitus [3, 4], inflammation [5] and diseases of aging [6].”
BackgroundSabbir, M. G. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1469751 · Cited by 11
Hayden, M. R., & Tyagi, N. (2024) · Pharmaceuticals · doi:10.3390/ph17121741 · Cited by 13
Karagoz, A., Savran, T., & Yılmaz, İ. (2025) · Journal of Fluorescence · doi:10.1007/s10895-025-04212-2 · Cited by 11
Raj, S. K., Rathod, N. H., Tripathi, B., Patidar, R., & Kulshrestha, V. (2021) · Nano Select · doi:10.1002/nano.202100127 · Cited by 11
Xu, J., Sun, W., & Li, Y. (2019) · Medicine · doi:10.1097/md.0000000000018189 · Cited by 11
“An autopsy of 11 patients with cognitive impairment by the Institute of Psychiatry of University of London showed that the iron content in the patients’ superior temporal gyrus was 15 to 20 times higher than that in the control group.([8]) This pathological change was closely related to gender and iron metabolism gene…”
BackgroundContribution of aging oral microbiota in getting neurodegenerative diseases
Karbalaei, M., Keikha, M., Yousefi, B., Ali‐Hassanzadeh, M., & Eslami, M. (2020) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000245 · Cited by 11
“first discovered by an English physician, James Parkinson in 1817, while the Alzheimer’s disease described by a German physician, Alois Alzheimer in 1906 [1].”
BackgroundBaltacı, N. G., Toraman, E., Akyüz, M., Kalın, Ş. N., & Budak, H. (2022) · BioMetals · doi:10.1007/s10534-022-00435-z · Cited by 11
“In addition to the various disorders caused by disturbances in cellular iron levels, local mismanagement of iron also has a functions in many diseases (Double et al., 2000; Benarroch, 2009; Altamura & Muckenthaler, 2009; Bandyopadhyay & Rogers, 2014).”
BackgroundBettegazzi, B., Pelizzoni, I., Scarzella, F. S., Restelli, L. M., Zacchetti, D., Maltecca, F., Casari, G., Grohovaz, F., & Codazzi, F. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4721950 · Cited by 10
Xu, Y., Yu, X., Chen, M., Sun, Y., Zhang, W., Fang, Y., Fang, L., Na, H., Liu, F., & Zhu, J. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.147272 · Cited by 10
A novel zero valent metal bismuth for bromate removal: direct and ultraviolet enhanced reduction
Huang, H., Liu, G., & Wang, X. (2020) · RSC Advances · doi:10.1039/c9ra10391k · Cited by 10
Zhang, Z.-H., Zhang, X., Wang, P., Xu, S.-H., Liang, Z., Ye, C., & Wang, X. (2024) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2024.124834 · Cited by 9
Firdhous, R. R., Dhanapal, S., Kosiha, A., Kalaiarasi, G., Ayyar, M., Guganathan, L., Lalitha, G., & Santhamoorthy, M. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.142080 · Cited by 9
Girotra, T., Mahajan, A., & Sidiropoulos, C. (2017) · Case Reports in Neurological Medicine · doi:10.1155/2017/5146723 · Cited by 9
“Excess iron can further lead to direct injury to the mitochondria [11].”
BackgroundTalib, J., & Davies, M. J. (2016) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-016-1340-4 · Cited by 9
The Role of Iron Overload in Diabetic Cognitive Impairment: A Review
An, J., Wang, Q., Sun, G.-Y., Su, J., Liu, J., Zhang, C., Wang, L., Teng, D., Yang, Y., & Shi, Y. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s432858 · Cited by 9
“101,102 The biological function of iron is based on its redox ability, that is, the interconversion between the ferrous and ferric states.”
BackgroundBioactive Compound‐Fortified Nanocarriers in the Management of Neurodegenerative Disease: A Review
Singh, A., Maheshwari, S., Yadav, J. P., Kumar, R. K., Verma, A., Singh, S. K., & Prajapati, B. G. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402018 · Cited by 8
“Similarly, multiple sclerosis modelsexhibitalteredferritinexpressioninaffectedregions[142].”
Is it oxidative or free radical stress and why does it matter?
Lipiński, B. (2012) · Oxidants and Antioxidants in Medical Science · doi:10.5455/oams.130312.rv.001 · Cited by 10
“These pathologic conditions include thrombosis [22], atherosclerosis [23], Parkinson’s and Alzheimer's diseases [24], cancer [25], age-related degenerations [26], kidney diseases [27] and neurological disorders [28, 29].”
BackgroundSharma, R., Chhibber, M., & Mittal, S. K. (2015) · RSC Advances · doi:10.1039/c5ra00969c · Cited by 8
De, S., Sarkar, B., Jadhav, G., Ramasamy, S. K., Banerjee, S., Moorthy, A., Paira, P., & K, A. K. S. (2018) · ChemistrySelect · doi:10.1002/slct.201801448 · Cited by 8
Amyloid Beta (Aβ) and Oxidative Stress: Progression of Alzheimer’s Disease
Haque, R. (2018) · Advances in Biotechnology & Microbiology · doi:10.19080/aibm.2018.11.555802 · Cited by 9
Kalaiarasi, G., Ranjani, M., Aswathy, M. P., Kosiha, A., & Prabhakaran, R. (2023) · ChemistrySelect · doi:10.1002/slct.202302891 · Cited by 7
dos Santos, B. L. B., Vieira, Y., Taleb, M. F. A., Ibrahim, M. M., Reis, M. A., do Nascimento, B. F., Oliveira, M. L. S., Silva, L. F. O., & Dotto, G. L. (2024) · Journal of Environmental Management · doi:10.1016/j.jenvman.2024.120893 · Cited by 7
Litvinenko, I., Вячеславович, К. И., & Trufanov, A. G. (2018) · Bulletin of the Russian Military Medical Academy · doi:10.32863/1682-7392-2018-3-63-68-77 · Cited by 7
Wang, M., Zhao, Y., Shi, J., Wang, Q., Zhao, L., & Li, S. (2025) · Journal of Fluorescence · doi:10.1007/s10895-025-04534-1 · Cited by 6
Sharma, A., Kirti, Kumari, A., Srivastava, D. N., & Paul, P. (2023) · ChemistrySelect · doi:10.1002/slct.202301249 · Cited by 6
Leaching behavior of iron from simulated landfills with different operational modes
Li, W., Yao, J., Xia, F.-F., Feng, H., Feng, H. D., Jiang, C., Fang, C., & Shen, D. (2011) · Bioresource Technology · doi:10.1016/j.biortech.2011.05.024 · Cited by 6
Hyeun, J.-A., Kim, J. Y., Kim, C. H., Kim, J., Lee, E. Y., & Seo, J. H. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02764-x · Cited by 6
The role of oxidative stress in the development of Alzheimer's disease
Nikolenko, V. N., Rizaeva, N. A., Bulygin, K. V., Anokhina, V. M., & Bolotskaya, A. A. (2022) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2022-4-68-74 · Cited by 7
Probable RBD Associates with the Development of RLS in Parkinson’s Disease: A Cross-Sectional Study
Qu, Y., Zhang, L., Shen, D., Zhang, W., Zhang, M., & Pan, Y. (2019) · Behavioural Neurology · doi:10.1155/2019/7470904 · Cited by 8
“The nigrostriatal pathway is one of the main regions of iron deposition in brain [47].”
BackgroundCholinesterase Inhibitors from the Aerial Part of Piper hymenophyllum
Dung, H. V., Cuong, T. D., Chinh, N. M., Quyen, D., Byeon, J. S., Kim, J. A., Woo, M. H., Choi, J. S., & Min, B. S. (2014) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2014.35.2.655 · Cited by 6
Faramarzi, M., Sadighi, M., Chitsazi, M., Esmailzadeh, M., & Foladvand, G. (2021) · Dental Research Journal · doi:10.4103/1735-3327.316656 · Cited by 6
“Despite the importance of iron in the body, imbalance in its amount can be associated with hemochromatosis and neuronal damage as a result of producing free radicals.[33] In the study of Amer et al.”
BackgroundRajbongshi, H., Sarkar, A., Phukan, P., Bhattacharjee, S., & Datta, P. (2019) · Journal of Materials Science Materials in Electronics · doi:10.1007/s10854-019-00852-w · Cited by 5
Drosophila models for studying iron-related neurodegenerative diseases.
Zhu, Z.-J., Wu, K.-C., Qian, Z., Yung, W., & Ke, Y. (2014) · PubMed · Cited by 5
Metadata
- Authors
- Altamura, S., & Muckenthaler, M. U.
- Affiliations
- University Hospital Heidelberg (DE)
- Corresponding author
- Muckenthaler, Martina U.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2009-04-17
- Volume
- 16
- Issue
- 4
- Pages
- 879-895
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1785761853
- Cited by
- 369
- References
- 190
- Citations by year
- 2026: 5 · 2025: 15 · 2024: 13 · 2023: 17 · 2022: 26 · 2021: 22 · 2020: 25 · 2019: 28 · 2018: 26 · 2017: 22 · 2016: 22 · 2015: 16 · 2014: 30 · 2013: 23 · 2012: 19
- FWCI
- 17.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Baden-Württemberg Stiftung
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron toxicity, brain iron accumulation
- MeSH terms
- Aging, Alzheimer Disease, Animals, Brain, Humans, Iron, Parkinson Disease, Oxidative Stress, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.